Cumberland Pharmaceuticals Inc. (CPIX) Gross margin 2016–2025
Cumberland Pharmaceuticals Inc. (CPIX) gross margin by fiscal year — reported gross profit divided by reported revenue.
85.0%FY2025 · since FY2016: 81.7% → 85.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 85.0% | +2.4 pp |
| FY2024 | 82.6% | -2.1 pp |
| FY2023 | 84.7% | +6.4 pp |
| FY2022 | 78.3% | +3.4 pp |
| FY2021 | 74.9% | -1.0 pp |
| FY2020 | 75.9% | -1.2 pp |
| FY2019 | 77.1% | -2.0 pp |
| FY2018 | 79.1% | -2.6 pp |
| FY2017 | 81.7% | +0.1 pp |
| FY2016 | 81.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CPIX financial trends
CPIX RevenueCPIX Net incomeCPIX Net marginCPIX Gross profitCPIX Operating incomeCPIX Operating marginCPIX Operating cash flowCPIX Free cash flowCPIX Capital expendituresCPIX Return on equityCPIX Stock buybacksCPIX Dividends paidCPIX Total assetsCPIX Total liabilitiesCPIX Shareholders’ equityCPIX overview →